These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22588588)
1. Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring. Marengo MF; Waimann CA; de Achaval S; Zhang H; Garcia-Gonzalez A; Richardson MN; Reveille JD; Suarez-Almazor ME Lupus; 2012 Oct; 21(11):1158-65. PubMed ID: 22588588 [TBL] [Abstract][Full Text] [Related]
2. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Mok CC; Ho LY; Cheung MY; Yu KL; To CH Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189 [TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627 [TBL] [Abstract][Full Text] [Related]
4. The effect of menopause on disease activity in systemic lupus erythematosus. Urowitz MB; Ibañez D; Jerome D; Gladman DD J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295 [TBL] [Abstract][Full Text] [Related]
5. Adherence to medications in systemic lupus erythematosus. Koneru S; Kocharla L; Higgins GC; Ware A; Passo MH; Farhey YD; Mongey AB; Graham TB; Houk JL; Brunner HI J Clin Rheumatol; 2008 Aug; 14(4):195-201. PubMed ID: 18636020 [TBL] [Abstract][Full Text] [Related]
6. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821 [TBL] [Abstract][Full Text] [Related]
7. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232 [TBL] [Abstract][Full Text] [Related]
8. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895 [TBL] [Abstract][Full Text] [Related]
9. Outcome measures to be used in clinical trials in systemic lupus erythematosus. Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993 [TBL] [Abstract][Full Text] [Related]
10. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study. Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983 [TBL] [Abstract][Full Text] [Related]
12. Medication Adherence in Chinese Patients With Systemic Lupus Erythematosus. Du X; Chen H; Zhuang Y; Zhao Q; Shen B J Clin Rheumatol; 2020 Apr; 26(3):94-98. PubMed ID: 30601165 [TBL] [Abstract][Full Text] [Related]
13. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. Becker-Merok A; Nossent HC J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708 [TBL] [Abstract][Full Text] [Related]
14. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. Chaiamnuay S; Bertoli AM; Fernández M; Apte M; Vilá LM; Reveille JD; Alarcón GS; J Clin Rheumatol; 2007 Jun; 13(3):128-33. PubMed ID: 17551377 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus. Aldar H; Lapa AT; Bellini B; Sinicato NA; Postal M; Fernandes PT; Costallat LT; Marini R; Appenzeller S Lupus; 2012 Oct; 21(11):1225-31. PubMed ID: 22740428 [TBL] [Abstract][Full Text] [Related]
16. Socioeconomic status and health in women with systemic lupus erythematosus. Lotstein DS; Ward MM; Bush TM; Lambert RE; van Vollenhoven R; Neuwelt CM J Rheumatol; 1998 Sep; 25(9):1720-9. PubMed ID: 9733452 [TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage. Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146 [TBL] [Abstract][Full Text] [Related]
18. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Daleboudt GM; Broadbent E; McQueen F; Kaptein AA Arthritis Care Res (Hoboken); 2011 Mar; 63(3):342-50. PubMed ID: 21120967 [TBL] [Abstract][Full Text] [Related]
19. The relationship between alexithymia and psychological factors in systemic lupus erythematosus. Barbosa F; Mota C; Patrício P; Alcântara C; Ferreira C; Barbosa A Compr Psychiatry; 2011; 52(6):754-62. PubMed ID: 21193176 [TBL] [Abstract][Full Text] [Related]
20. Role of specialty care in the management of patients with systemic lupus erythematosus. Urowitz MB; Kagal A; Rahman P; Gladman DD J Rheumatol; 2002 Jun; 29(6):1207-10. PubMed ID: 12064836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]